Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Mar 4, 2024
Dr. Doron Behar, Co-Founder and CEO of Igentify, has a vision for the future of genetic counseling, where patients get the support they need to interpret and understand genetic screening results before the tests as well as after. With a shortage of genetic counselors, the solution, in part, lies in using technology to reduce waiting times and improve the interpretation of results while allowing the counselors to handle more patients effectively. The Igentify platform aims to support end-to-end services to provide precision medicine solutions to patients to meet specific needs and identify what test results might indicate about future health.
Doron explains, "We need to first speak about the genomic revolution and the crucial role of genetic counseling in it. So, as we know, we are all currently going through the genomic revolution, which means that we are anticipating that each of us will have genomic information, the full content of the genome, inside the medical record. The genetic counselors are the ones who are responsible for interpreting for us and explaining to us what our genome is telling us about our future health."
"And particularly, the genome can identify potential risks that we might want to know about, whether it is related to reproductive health, cancer risk, or the use of drug pharmacogenomics. We can see literature saying that even recently, there were more than 5 million genetic tests sold in 2021. Less than 6,000 genetic counselors can present the information to the patients, and they are in North America. And if we compare to the world, there are only 7,500 genetic counselors globally."
"The force model will allow us to use the digital genetic assistant and send information back to the patients, creating an end-to-end solution. Very importantly, we are using advanced and sophisticated multimedia content to approach the patients either in the pre- or in the post-test scenarios. These multimedia components allow speaking with the patients about their own situation. So maintaining a very high level of personalization, even speaking different languages to the patients, is particularly important, for example, to make sure that patients understand."
#Igentify #GeneticCounseling #GeneticScreening #GeneticTesting #GeneticMedicine #DigitalHealth #PrecisionMedicine
